Preconditioning of the immune system modulates the response of papillary thyroid cancer to immune checkpoint inhibitors.
Fabiana PaniYoshinori YasudaSylvie T RousseauKevin C BermeaSolmaz RoshanmehrRulin WangSrinivasan YegnasubramanianPatrizio CaturegliLuigi AdamoPublished in: Journal for immunotherapy of cancer (2022)
Response to ICIs depends on the status of the immune system of the treated individual. Modulation of the immune system should be explored as a tool to improve response to ICIs in patients with PTC or other forms of cancer.